¼ºñ½º »óǰ
¸®¼Ä¡ Á¤º¸
°í°´¼¾ÅÍ
°øÁö»çÇ×
´Ù¿î·Îµå
Financial
Information
e-Bond
Revolution
Market
Transparency
BONDWEB ½Ã½ºÅÛÀº ²÷ÀÓ¾ø´Â Á¤º¸Çõ½ÅÀ» ÅëÇØ ±ÝÀ¶ ¼±ÁøÈ¿¡ ±â¿©ÇÕ´Ï´Ù.
BONDWEB
º»µåÀ¥Plus
ÃֱٰԽù°
°æÁ¦Á¾ÇÕ´º½º
º¸µµÀÚ·á
½Ã°¡Æò°¡Ç¥
ÁÖ¿ä±Ý¸®
IRS/CRS
½ºÅ©·¦
ÇïÇÁµ¥½ºÅ©
´Ù¿î·Îµå¼¾ÅÍ
°øÁö»çÇ× & ´º½º
ÀÎÀçã±â
ENG
ÀÏÀÚ
ÆÄÀÏ
Á¦¸ñ
±â°ü¸í
02-27
(¹Ì·¡¿¡¼ÂÁõ±Ç À¯¸í°£) Week Ahead Snapshot : ´ÙÀ½ ÁÖ ÁÖ¸ñÇÒ ±Ý..
¹Ì·¡¿¡¼Â´ë¿ì
02-27
[ÇコÄɾî] ¼öÇýÀÇ ½ÃÁð
»ï¼ºÁõ±Ç
02-27
¹Ì±¹ ¸¶°¨½ÃȲ : ±â¼úÁÖ Áß½ÉÀ¸·Î ¹Ýµî¼¼ ¿¬Àå
»ï¼ºÁõ±Ç
02-27
[¸ðµÎÀÇ ETP Biweekly] ETPrism: ±Û·Î¹ú ETF Picks
»ï¼ºÁõ±Ç
02-27
<¿ù°£Àü¸Á - 2026.03> Global Equity Insights : ÇǷΰ¨ÀÌ À¯ÀÏ ..
»ï¼ºÁõ±Ç
02-27
[ÈÇÐ] ÁÖÁÖ °ü¿© È®´ë ±¹¸é, Who's next?
»ï¼ºÁõ±Ç
02-27
<¿ù°£Àü¸Á - 2026.03> US Equity Insights 3¿ù: º¯µ¿¼º °ü¸®¿Í ±â..
»ï¼ºÁõ±Ç
02-27
[¿£ºñµð¾Æ (NAS:NVDA)] FY 4Q26 review - Accelerating, Again
»ï¼ºÁõ±Ç
02-27
[Onconic Therapeutics (476060)] Momentum remains
»ï¼ºÁõ±Ç
02-27
[½º³ë¿ìÇ÷¹ÀÌÅ© (NYS:SNOW)] F4Q26 Review - µ¥ÀÌÅÍ ÅëÇÕ ·¹À̾î..
»ï¼ºÁõ±Ç
02-27
±¹³» ¸¶°¨½ÃȲ : AI ÅõÀڽɸ®¿¡ ºÒ ºÙÀÎ ¿£ºñµð¾Æ
»ï¼ºÁõ±Ç
02-27
<ä±ÇÀϰ£ - 260226> 2¿ù ±ÝÅëÀ§ Review Çѱ¹ÀºÇà °æÁ¦Àü¸Á »óÇâ..
»ï¼ºÁõ±Ç
02-27
[¼¼ÀϽºÆ÷½º (NYS:CRM)] F4Q26 Review - Àڽۨ°ú ¼ýÀÚÀÇ ±«¸®
»ï¼ºÁõ±Ç
02-27
[Chemicals] Shareholder engagement expanding: Who¡¯s next?
»ï¼ºÁõ±Ç
02-27
¹Ì±¹ ¸¶°¨½ÃȲ : ¿£ºñµð¾Æ ¾à¼¼ ºÎ°¢µÇ¸ç Ç϶ô
»ï¼ºÁõ±Ç
Àüü : 364
óÀ½
ÀÌÀü
[1]
[2]
[3]
[4]
[5]
´ÙÀ½
³¡À¸·Î
Ȩ > ¸®¼Ä¡Á¤º¸ >
ÃֱٰԽù°